Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon

Summary

The purpose of this research study is to test the safety, tolerability, and effectiveness of Topical AmphiMatrix with Nitroglycerin (MQX-503) to relieve Raynaud's symptoms and increase blood flow to the fingers.

Timeline

Start

2006-12

Primary completion

—

Completion

—

Drugs

Indications